Eisai
Rongzhen Lu is a seasoned scientist with a robust background in molecular biology and biochemistry, holding a post-doctoral degree from Harvard University and a Ph.D. in Veterinary Medicine from The University of Tokyo. With extensive experience in the pharmaceutical industry, Rongzhen Lu has held prominent positions including Sr. Scientist and Team Leader at Eisai, and has served as a Research Scientist II at Biogen Idec. Previous roles also include Principal Scientist/Sr. Scientist at Synta Pharmaceuticals and Sr. Scientist/Scientist at SBR BioResearch, showcasing a diverse and impactful career in research and leadership within the scientific community.
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.